PRODUCT BROCHURE
Flowfect Discover™ - Accelerate cell therapy discovery, optimization, and development
DOWNLOAD PDF
Flowfect Tx™ - Expedite cell therapy development and manufacturing
ESGCT 2022
Delivery of mRNA and CRISPR-Cas9 RNP to primaryNatural Killer cells and T cells using Flowfect®,a new transfection technology
ISCT 2022
CRISPR-Cas9 RNP editing of primary T cells using the Flowfect® transfection technology platform
ASGCT 2022
CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform
ASGCT2020
Flowfect®: A scalable non-viral delivery process for T cell engineering
ISSCR 2020
Flowfect® Transfection of iPSCs Maintains Cell Pluripotency
Scientific Reports
Microfluidic screening of electric fields for electroporation
BioRxiv 2021
Electro-mechanical transfection for non-viral primary immune cell engineering